Concepedia

Vivien Rothe

VR

Statistics

Publications

5

Citations

396

H-Index

5

Active since

2011

Affiliations

Roche (Switzerland)(Current)

Hôpital Beaujon

Azienda Ospedaliera Universitaria Pisana

Ankara University

Vivien Rothe is an author at Roche (Switzerland) specializing in viral hepatitis, interferon-based therapy, and hepatitis pharmacotherapy.

Publications per year

2011–2020

5

Publications

5

Hepatitis B surface antigen levels: association with 5-year response to peginterferon alfa-2a in hepatitis B e-antigen-negative patients

Patrick Marcellin, Ferruccio Bonino, Cihan Yurdaydın et al. · Hepatology International · 2012 · 158 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Hepatitis B surface antigen: association with sustained response to peginterferon alfa-2a in hepatitis B e antigen-positive patients

Teerha Piratvisuth, Patrick Marcellin, M. Popescu et al. · Hepatology International · 2011 · 114 citations

Pharmacy, Immunology, Infectious Diseases +10

Response to peginterferon alfa-2a (40KD) in HBeAg-negative CHB: On-treatment kinetics of HBsAg serum levels vary by HBV genotype

Maurizia Rossana Brunetto, Patrick Marcellin, B. Cherubini et al. · Journal of Hepatology · 2013 · 93 citations

Pharmacy, Pharmacokinetics, Pharmacotherapy +13

Serum Levels of Hepatitis B Surface Antigen Predict Severity of Fibrosis in Patients With E Antigen-Positive Chronic Hepatitis B

Patrick Marcellin, Michelle Martinot-Peignoux, Tarik Asselah et al. · Clinical Gastroenterology and Hepatology · 2014 · 20 citations

Medicine, Infectious Diseases, Clinical Classification Systems +16

Noninferiority of cetuximab every-2-weeks versus standard once-weekly administration schedule for the first-line treatment of RAS wild-type metastatic colorectal cancer

Stefan Kasper, Caroline Foch, Diethelm Messinger et al. · European Journal of Cancer · 2020 · 11 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 5